Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

NCT00439140 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

41

Enrollment

INDUSTRY

Sponsor class

Stopped In agreement with FDA the study was terminated based on data available.

Conditions

Overactive Bladder

Interventions

BIOLOGICAL: botulinum toxin Type A
DRUG: Normal Saline (Placebo)

Sponsor

Allergan